CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −11,225 | $21.88 | $246K | 203,007 |
| 2025-12-16 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −6,702 | $21.88 | $147K | 80,436 |
| 2025-12-16 | Jaen Juan C. President | Sale 10b5-1 | −11,225 | $21.88 | $246K | 355,995 |
| 2025-12-16 | ROSEN TERRY J Chief Executive Officer | Sale 10b5-1 | −28,947 | $21.88 | $633K | 2,220,553 |
| 2025-12-04 | Jaen Juan C. President | Sale 10b5-1 | −82,997 | $24.71 | $2.1M | 954,063 |
| 2025-11-26 | Azoy Alexander Chief Accounting Officer | Option exercise 10b5-1 | +1,900 | $13.33 | $25K | 29,263 |
| 2025-11-26 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −1,900 | $26.00 | $49K | 27,363 |
| 2025-11-26 | Azoy Alexander Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −1,900 | 9,500 | ||
| 2025-11-26 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −5,000 | $25.00 | $125K | 87,138 |
| 2025-11-18 | Jaen Juan C. President | Sale 10b5-1 | −5,050 | $19.75 | $100K | 1,037,060 |
| 2025-11-17 | Jaen Juan C. President | Sale 10b5-1 | −37,114 | $20.23 | $751K | 1,049,946 |
| 2025-11-17 | Jaen Juan C. President | Sale 10b5-1 | −7,836 | $20.71 | $162K | 1,042,110 |
| 2025-11-07 | Jarrett Jennifer Chief Operating Officer | Option exercise 10b5-1 | +50,291 | $1.23 | $62K | 264,523 |
| 2025-11-07 | Jarrett Jennifer Chief Operating Officer | Sale 10b5-1 | −50,291 | $18.97 | $954K | 214,232 |
| 2025-11-07 | Jarrett Jennifer Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,291 | $1.23 | $62K | 80,583 |
| 2025-10-30 | Jaen Juan C. President | Sale 10b5-1 | −4,314 | $20.32 | $88K | 1,087,060 |
| 2025-10-29 | Jaen Juan C. President | Sale 10b5-1 | −47,675 | $20.49 | $977K | 1,121,539 |
| 2025-10-29 | Jaen Juan C. President | Sale 10b5-1 | −29,365 | $21.53 | $632K | 1,092,174 |
| 2025-10-29 | Jaen Juan C. President | Sale 10b5-1 | −800 | $22.04 | $18K | 1,091,374 |
| 2025-10-28 | Jaen Juan C. President | Sale 10b5-1 | −19,019 | $20.19 | $384K | 1,169,214 |
Page 4 of 9 · 177 trades